MMUT: A Potential Drug Target for Cancer (G4594)

Target Name: MMUT

NCBI ID: G4594

MMUT

MMUT: A Potential Drug Target for Cancer

Methylmalonyl Coenzyme A mutase (MMUT) is an enzyme that plays a crucial role in the metabolism of aromatic amino acids, which are important building blocks of many drugs, including anti-cancer agents. MMUT is also an enzyme that is often targeted by drug development companies as potential drug targets or biomarkers.

MMUT is a member of the Coenzyme A (COA) enzyme family, which is responsible for the final step in the biosynthesis of aromatic amino acids. The primary function of this enzyme is to convert the methyl group that is attached to the carbon atom of the amino acid into a reactive oxygen atom, which can then react with other amino acids to form a cyclic structure.

MMUT is expressed in many different tissues and cells in the body, including the brain, heart, and gastrointestinal tract. It is also highly expressed in cancer cells, which makes it an attractive target for drug developers.

One of the main reasons why MMUT is being targeted by drug developers is because of its role in the metabolism of aromatic amino acids. Many drugs that are used to treat cancer and other diseases work by interfering with the biosynthesis of these amino acids. By inhibiting the activity of MMUT, these drugs can inhibit the growth and spread of cancer cells.

Another reason why MMUT is being targeted is because of its high expression in cancer cells. As mentioned above, MMUT is highly expressed in cancer cells, which makes it an attractive target for drug developers. By targeting this enzyme, drugs can selectively target cancer cells and minimize their effects on healthy cells.

In addition to its role in the metabolism of aromatic amino acids, MMUT is also a potential biomarker for cancer. Because it is highly expressed in cancer cells, it can be used as a protein biomarker to track the progression of cancer. This can be important for identifying which patients are at risk of recurrence and for evaluating the effectiveness of different treatments.

MMUT is also a potential drug target because of its unique structure. The active site of MMUT is located on the carbon atom, which makes it a difficult target for drugs. However, this also means that drugs that target this site have a high potential for selectivity and minimizing side effects.

In conclusion, MMUT is an enzyme that plays a crucial role in the metabolism of aromatic amino acids and is highly expressed in cancer cells. As a result, it is an attractive target for drug development and has the potential to be a valuable biomarker for cancer . Further research is needed to fully understand the role of MMUT in cancer biology and to develop effective treatments.

Protein Name: Methylmalonyl-CoA Mutase

Functions: Catalyzes the reversible isomerization of methylmalonyl-CoA (MMCoA) (generated from branched-chain amino acid metabolism and degradation of dietary odd chain fatty acids and cholesterol) to succinyl-CoA (3-carboxypropionyl-CoA), a key intermediate of the tricarboxylic acid cycle

The "MMUT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMUT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets